Listed by the USPTO as LEESER, ERICH A
Tech Center 1600 • Art Units: 1622 1624
This examiner grants 82% of resolved cases
LEESER, ERICH A is assigned to Tech Center 1600 and Art Unit 1622. The profile records 971 resolved cases and an allowance rate of 81.9%. The median time to allowance is 767 days, providing a defined timing reference for applicants evaluating prosecution before this examiner.
Interviews are associated with a 13.3% lift. Shanghai Apeiron Therapeutics, Katholieke Universiteit Leuven, and Seoul National University R&DB Foundation are the leading listed applicants. Bayramoglu Law Offices, BIRCH STEWART KOLASCH & BIRCH, and Fox Rothschild are the leading listed firms. The record centers on biotechnology and therapeutic research activity.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18487809 | ANTI-VIRAL COMPOUNDS | Non-Final OA | Katholieke Universiteit Leuven |
| 18557991 | COMPOSITION FOR PROMOTING BONE FORMATION OR TREATING BONE DISEASE BY ACTING ON OSTEOBLAST MITOCHONDRIA | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18543130 | COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND TITANIUM DIOXIDE | Non-Final OA | L'OREAL |
| 18549158 | Treatment of Breast Cancer with Amcenestrant and Palbociclib | Non-Final OA | Pfizer Inc. |
| 18763484 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE | Non-Final OA | JANSSEN PHARMACEUTICA NV |
| 18409158 | OLANZAPINE COMPOSITIONS AND METHODS OF USE | Non-Final OA | MEDINCELL SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy81.9% of resolved applications examined by Erich A Leeser were allowed (971 resolved cases), compared with 60.6% across Art Unit 1622 over the last five years.
This examiner's interview lift is +13.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Erich A Leeser took 767 days on average from filing to allowance.
Erich A Leeser examines applications in Art Unit 1622 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
